Display options
Share it on

Exp Ther Med. 2022 Jan;23(1):6. doi: 10.3892/etm.2021.10928. Epub 2021 Oct 27.

Bioinformatics analysis and experimental validation of differentially expressed genes in mouse articular chondrocytes treated with IL-1β using microarray data.

Experimental and therapeutic medicine

Fan Liang, Le Peng, Yong-Gang Ma, Wei Hu, Wei-Bing Zhang, Ming Deng, Ya-Ming Li

Affiliations

  1. Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.

PMID: 34815758 PMCID: PMC8593859 DOI: 10.3892/etm.2021.10928

Abstract

Osteoarthritis (OA) is the most prevalent chronic degenerative disease that affects the health of the elderly. The present study aimed to identify significant genes involved in OA via bioinformatics analysis. A gene expression dataset (GSE104793) was downloaded from the Gene Expression Omnibus. Bioinformatics analysis was then performed in order to identify differentially expressed genes (DEGs) between untreated chondrocytes and chondrocytes cultured with interleukin-1β (IL-1β) for 24 h. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed using Metascape. A protein-protein interaction network of DEGs was constructed using the Search Tool for the Retrieval of Interacting Genes. Gene set enrichment analysis (GSEA) was performed using GSEA software. Furthermore, chondrocytes were extracted and treated with IL-1β (10 ng/ml) for 24 h, and reverse-transcription quantitative PCR was used to confirm differential expression of hub genes. Patient samples were also collected to verify the bioinformatic analysis results. Based on the cut-off criteria used for determination of the DEGs, a total of 844 DEGs, including 498 upregulated and 346 downregulated DEGs, were identified. The DEGs were mainly enriched in the GO terms and KEGG pathways 'inflammatory response', 'negative regulation of cell proliferation', 'ossification', 'taxis', 'blood vessel morphogenesis', 'extracellular structure organization', 'mitotic cell cycle process' and 'TNF signaling pathway'. The majority of the PCR results, namely the differential expression of kininogen 2, complement C3, cyclin B1, cell division cycle 20, cyclin A2, 1-phosphatidylinositol 4-kinase, BUB1 mitotic checkpoint serine/threonine kinase, kinesin family member 11, cyclin B2 and BUB1 mitotic checkpoint serine/threonine kinase B were consistent with the bioinformatics results. Collectively, the present observations provided a regulation network of IL-1β-stimulated chondrocytes, which may provide potential targets of OA therapy.

Copyright: © Liang et al.

Keywords: bioinformatics analysis; differentially expressed genes; osteoarthritis

Conflict of interest statement

The authors declare that they have no competing interests.

References

  1. Nat Commun. 2020 May 1;11(1):2132 - PubMed
  2. Chem Biol Interact. 2018 Apr 25;286:45-51 - PubMed
  3. Br J Nutr. 2013 Jul 28;110(2):241-55 - PubMed
  4. Oncol Lett. 2020 Aug;20(2):1695-1708 - PubMed
  5. J Mol Cell Cardiol. 2020 Aug;145:1-13 - PubMed
  6. Arthritis Rheum. 2000 Jan;43(1):215-25 - PubMed
  7. Biochemistry. 2004 Apr 27;43(16):4791-8 - PubMed
  8. Osteoarthritis Cartilage. 2020 Sep;28(9):1154-1169 - PubMed
  9. Inflammation. 2020 Oct;43(5):1742-1750 - PubMed
  10. Sci Rep. 2020 May 20;10(1):8372 - PubMed
  11. BMC Musculoskelet Disord. 2020 May 29;21(1):332 - PubMed
  12. Arthroscopy. 2020 May;36(5):1452-1464.e2 - PubMed
  13. Pain Res Manag. 2020 Mar 10;2020:7587936 - PubMed
  14. Drug Des Devel Ther. 2020 Mar 26;14:1227-1240 - PubMed
  15. Vet J. 2016 Mar;209:40-9 - PubMed
  16. Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):1875-80 - PubMed
  17. JAMA. 2018 Dec 25;320(24):2564-2579 - PubMed
  18. Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6698-703 - PubMed
  19. Mol Med Rep. 2015 Oct;12(4):5211-6 - PubMed
  20. Drugs Aging. 2019 Apr;36(Suppl 1):45-64 - PubMed
  21. Inflamm Res. 2020 Jun;69(6):619-630 - PubMed
  22. Exp Ther Med. 2019 Sep;18(3):2079-2085 - PubMed
  23. Transl Lung Cancer Res. 2020 Apr;9(2):218-231 - PubMed
  24. Sci Rep. 2020 May 5;10(1):7558 - PubMed
  25. Exp Ther Med. 2019 Apr;17(4):2614-2622 - PubMed
  26. Sci Rep. 2019 Dec 19;9(1):19437 - PubMed
  27. Oncol Lett. 2020 Oct;20(4):60 - PubMed
  28. J Hazard Mater. 2021 Sep 5;417:125997 - PubMed
  29. J Int Med Res. 2020 Jul;48(7):300060520910019 - PubMed
  30. Nat Commun. 2019 Apr 3;10(1):1523 - PubMed
  31. J Exp Med. 2005 May 2;201(9):1355-9 - PubMed
  32. Methods Mol Biol. 2011;696:291-303 - PubMed
  33. Drug Des Devel Ther. 2020 Jul 07;14:2645-2655 - PubMed
  34. Biochem Biophys Res Commun. 2020 Jun 25;527(2):458-465 - PubMed
  35. Int Immunopharmacol. 2020 Aug;85:106612 - PubMed
  36. J Orthop Translat. 2019 Aug 06;22:14-25 - PubMed
  37. Exp Cell Res. 2018 May 15;366(2):81-91 - PubMed
  38. Yonsei Med J. 2018 Aug;59(6):760-768 - PubMed

Publication Types